GRAFTECH INTERNATIONAL LTD. - 10-Q Summary (Q2 2025)
Business Context and Reporting Period
This report covers the quarterly period ended June 30, 2025. GrafTech International Ltd. is a leading manufacturer of graphite electrodes essential for electric arc furnace (EAF) steel production and petroleum needle coke. The company operates as a single reportable segment (Industrial Materials) and is vertically integrated, producing its key raw material, needle coke.
Key Financial Metrics
| Metric | Q2 2025 | Q2 2024 | YTD 2025 | YTD 2024 |
|---|---|---|---|---|
| Net Sales | $131.8M | $137.3M | $243.7M | $273.9M |
| Gross Profit (Loss) | $0.1M | $4.0M | $(1.6M) | $2.7M |
| Operating Loss | $(14.6M) | $(2.7M) | $(32.8M) | $(24.0M) |
| Net Loss | $(86.9M) | $(14.8M) | $(126.2M) | $(45.6M) |
| Loss Per Share (Diluted) | $(0.34) | $(0.06) | $(0.49) | $(0.18) |
| Adjusted EBITDA | $3.5M | $14.5M | $(0.2M) | $14.7M |
| Cash & Equivalents | $158.5M | $176.9M (YTD start) | $158.5M | $120.7M (YTD end) |
| Total Debt | $1.09B | $1.09B | $1.09B | $1.09B |
| Liquidity | $366.5M | N/A | $366.5M | N/A |
Note: Liquidity includes cash, $108M available under the 2018 Revolving Credit Facility, and $100M under the Delayed Draw First Lien Term Loan Facility.
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 4% QoQ and 11% YTD due to a 12% drop in weighted-average realized price ($4,200/MT), partially offset by a 12% increase in sales volume (28.6k MT).
- Significant Net Loss Increase: Q2 net loss widened to $86.9M from $14.8M in Q2 2024. This was primarily driven by a $42.6M non-cash income tax expense resulting from a full valuation allowance against U.S. and Switzerland deferred tax assets.
- Interest Expense Surge: Interest expense increased 63% QoQ ($25.4M vs $15.6M) due to new First Lien Term Loans and $0.9M in debt modification costs.
- SG&A Volatility: Selling and administrative expenses rose 160% QoQ ($13.3M vs $5.1M). Excluding a $9.2M legal fee reimbursement received in Q2 2024, underlying expenses actually decreased due to cost rationalization.
- Inventory Build: Cash flow used for inventories increased significantly ($46.4M YTD) as the company level-loads production to manage costs.
Guidance, Outlook, and Risks
- Volume Outlook: Management expects an approximate 10% year-over-year increase in full-year 2025 sales volume as they regain market share, particularly in the U.S.
- Cost Outlook: Cash cost of goods sold per MT is expected to decline 7-9% year-over-year for 2025, exceeding previous guidance.
- Profitability: Adjusted EBITDA for the second half of 2025 is anticipated to be near breakeven.
- Capital Expenditures: Full-year 2025 CapEx is expected to be approximately $40 million.
- NYSE Listing Risk: The company's stock price does not currently comply with NYSE minimum bid price requirements. A reverse stock split is proposed for shareholder approval at a special meeting expected on August 14, 2025, to maintain listing status.
- Legal Contingencies: Significant pending litigation includes a Brazil wage claim (Clause IV) where potential losses are currently unquantifiable, and securities/derivative lawsuits regarding the 2022 Monterrey facility suspension.
Investor Verification Checklist
- Valuation Allowance Impact: Verify the permanence of the $42.6M tax valuation allowance and its effect on future effective tax rates.
- Debt Covenant Compliance: Confirm continued compliance with financial covenants, specifically the Senior Secured First Lien Net Leverage Ratio, which limits access to the $108M revolving credit facility.
- Reverse Stock Split Approval: Monitor the outcome of the August 2025 shareholder vote on the reverse stock split to assess delisting risk.
- Price Realization: Track the execution of the announced 15% price increase on uncommitted 2025 volume to see if it mitigates the current pricing pressure.
- Working Capital Trends: Monitor the sustainability of the inventory build-up and its impact on operating cash flow.